Phreesia (NYSE:PHR) Given $33.00 Average Target Price by Brokerages

Share on StockTwits

Shares of Phreesia (NYSE:PHR) have earned an average broker rating score of 1.00 (Strong Buy) from the five brokers that cover the stock, Zacks Investment Research reports. Five equities research analysts have rated the stock with a strong buy rating.

Analysts have set a 1-year consensus target price of $33.00 for the company, according to Zacks. Zacks has also given Phreesia an industry rank of 104 out of 256 based on the ratings given to its competitors.

Several brokerages recently commented on PHR. Wells Fargo & Co began coverage on Phreesia in a report on Monday. They set an “outperform” rating and a $23.00 target price on the stock. Chardan Capital started coverage on Phreesia in a report on Tuesday, July 23rd. They issued a “buy” rating and a $33.00 target price for the company. William Blair started coverage on Phreesia in a report on Monday. They issued an “outperform” rating for the company. Piper Jaffray Companies started coverage on Phreesia in a report on Monday. They issued an “overweight” rating and a $33.00 target price for the company. Finally, JPMorgan Chase & Co. started coverage on Phreesia in a report on Tuesday. They issued an “overweight” rating and a $33.00 target price for the company.

PHR traded down $0.82 on Friday, hitting $25.52. 8,315 shares of the company’s stock were exchanged, compared to its average volume of 788,914. Phreesia has a fifty-two week low of $23.00 and a fifty-two week high of $29.38.

In other Phreesia news, major shareholder Ii L.P. Chv sold 335,767 shares of the firm’s stock in a transaction on Monday, July 22nd. The shares were sold at an average price of $18.00, for a total value of $6,043,806.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Scott Perricelli sold 743,388 shares of the firm’s stock in a transaction on Monday, July 22nd. The shares were sold at an average price of $18.00, for a total transaction of $13,380,984.00. The disclosure for this sale can be found here.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments.

See Also: Net Income

Get a free copy of the Zacks research report on Phreesia (PHR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.